CNP and hereditary disease: Notably in subjects with genetic disorders of skeletal growth affecting CNP pathway activity plasma NTproCNP concentrations are raised where intra cellular CNP pathway activity is reduced5,6 and are reduced where intra cellular activity is enhanced7–9.